

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | muscle filament sliding (GO:0030049) | 6.61087872 |
| 2 | actin-myosin filament sliding (GO:0033275) | 6.61087872 |
| 3 | actin-mediated cell contraction (GO:0070252) | 5.70154935 |
| 4 | myofibril assembly (GO:0030239) | 5.35301708 |
| 5 | regulation of relaxation of muscle (GO:1901077) | 5.31178232 |
| 6 | sarcomere organization (GO:0045214) | 4.78033014 |
| 7 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.76435938 |
| 8 | cardiac myofibril assembly (GO:0055003) | 4.76154936 |
| 9 | skeletal muscle contraction (GO:0003009) | 4.63372675 |
| 10 | striated muscle contraction (GO:0006941) | 4.62875393 |
| 11 | actin filament-based movement (GO:0030048) | 4.59342984 |
| 12 | regulation of skeletal muscle contraction (GO:0014819) | 4.40309676 |
| 13 | synaptic vesicle maturation (GO:0016188) | 4.38483664 |
| 14 | cardiac muscle contraction (GO:0060048) | 4.36924847 |
| 15 | regulation of actin filament-based movement (GO:1903115) | 4.35778684 |
| 16 | cardiac muscle hypertrophy (GO:0003300) | 4.32373235 |
| 17 | striated muscle hypertrophy (GO:0014897) | 4.12180663 |
| 18 | glutamate secretion (GO:0014047) | 4.10230333 |
| 19 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.02795573 |
| 20 | actomyosin structure organization (GO:0031032) | 4.02287979 |
| 21 | response to inactivity (GO:0014854) | 3.93487541 |
| 22 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.92073554 |
| 23 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.89009734 |
| 24 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.88556990 |
| 25 | locomotory exploration behavior (GO:0035641) | 3.84140943 |
| 26 | skeletal muscle adaptation (GO:0043501) | 3.62127280 |
| 27 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.57818666 |
| 28 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.57653865 |
| 29 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.57302817 |
| 30 | synaptic vesicle exocytosis (GO:0016079) | 3.56410598 |
| 31 | muscle hypertrophy (GO:0014896) | 3.50686834 |
| 32 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.46201625 |
| 33 | muscle contraction (GO:0006936) | 3.45126249 |
| 34 | creatine metabolic process (GO:0006600) | 3.38231099 |
| 35 | striated muscle adaptation (GO:0014888) | 3.35357597 |
| 36 | response to muscle activity (GO:0014850) | 3.34850441 |
| 37 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.33382413 |
| 38 | cardiac muscle adaptation (GO:0014887) | 3.26014294 |
| 39 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.26014294 |
| 40 | muscle hypertrophy in response to stress (GO:0003299) | 3.26014294 |
| 41 | relaxation of cardiac muscle (GO:0055119) | 3.21934263 |
| 42 | regulation of synaptic vesicle transport (GO:1902803) | 3.21499008 |
| 43 | vocalization behavior (GO:0071625) | 3.20570048 |
| 44 | activation of protein kinase A activity (GO:0034199) | 3.18230693 |
| 45 | muscle system process (GO:0003012) | 3.15166510 |
| 46 | neurotransmitter secretion (GO:0007269) | 3.15090350 |
| 47 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.14776521 |
| 48 | plasma membrane repair (GO:0001778) | 3.14549262 |
| 49 | cell communication by electrical coupling (GO:0010644) | 3.12413742 |
| 50 | regulation of striated muscle contraction (GO:0006942) | 3.11959926 |
| 51 | layer formation in cerebral cortex (GO:0021819) | 3.10621606 |
| 52 | regulation of the force of heart contraction (GO:0002026) | 3.10151402 |
| 53 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.07138518 |
| 54 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.05615240 |
| 55 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.05171162 |
| 56 | adult heart development (GO:0007512) | 3.04535091 |
| 57 | cellular response to epinephrine stimulus (GO:0071872) | 3.00639573 |
| 58 | relaxation of muscle (GO:0090075) | 2.99365095 |
| 59 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.98533312 |
| 60 | response to epinephrine (GO:0071871) | 2.97904633 |
| 61 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.97745493 |
| 62 | carnitine shuttle (GO:0006853) | 2.97388204 |
| 63 | myotube differentiation (GO:0014902) | 2.96962711 |
| 64 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.96115415 |
| 65 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.95984394 |
| 66 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.94910795 |
| 67 | regulation of synapse structural plasticity (GO:0051823) | 2.94081846 |
| 68 | protein targeting to Golgi (GO:0000042) | 2.93823904 |
| 69 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.92312232 |
| 70 | positive regulation of cation channel activity (GO:2001259) | 2.92242994 |
| 71 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.92187664 |
| 72 | skeletal muscle fiber development (GO:0048741) | 2.92031720 |
| 73 | cellular potassium ion homeostasis (GO:0030007) | 2.91451575 |
| 74 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.91181800 |
| 75 | glucan catabolic process (GO:0009251) | 2.90687139 |
| 76 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.89791116 |
| 77 | neuronal action potential propagation (GO:0019227) | 2.89259575 |
| 78 | cardiac muscle cell development (GO:0055013) | 2.88916842 |
| 79 | cell communication involved in cardiac conduction (GO:0086065) | 2.88540686 |
| 80 | myotube cell development (GO:0014904) | 2.87657704 |
| 81 | sodium ion export (GO:0071436) | 2.87051359 |
| 82 | proline transport (GO:0015824) | 2.86462152 |
| 83 | muscle tissue morphogenesis (GO:0060415) | 2.85845409 |
| 84 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.83824379 |
| 85 | fatty acid transmembrane transport (GO:1902001) | 2.79969402 |
| 86 | gamma-aminobutyric acid transport (GO:0015812) | 2.79590196 |
| 87 | carnitine transmembrane transport (GO:1902603) | 2.79482182 |
| 88 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.78622091 |
| 89 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.77390164 |
| 90 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.76952799 |
| 91 | nucleus localization (GO:0051647) | 2.76859303 |
| 92 | establishment of protein localization to Golgi (GO:0072600) | 2.74598174 |
| 93 | vesicle transport along microtubule (GO:0047496) | 2.74249983 |
| 94 | muscle fiber development (GO:0048747) | 2.73927797 |
| 95 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.73812296 |
| 96 | macroautophagy (GO:0016236) | 2.73018251 |
| 97 | striated muscle atrophy (GO:0014891) | 2.72255985 |
| 98 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.72146861 |
| 99 | cellular polysaccharide catabolic process (GO:0044247) | 2.70585558 |
| 100 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.70378217 |
| 101 | cardiac cell development (GO:0055006) | 2.69756521 |
| 102 | exploration behavior (GO:0035640) | 2.68870354 |
| 103 | interkinetic nuclear migration (GO:0022027) | 2.68619719 |
| 104 | skeletal muscle tissue development (GO:0007519) | 2.64910980 |
| 105 | regulation of sarcomere organization (GO:0060297) | 2.62634342 |
| 106 | cardiac muscle cell action potential (GO:0086001) | 2.61155062 |
| 107 | carnitine transport (GO:0015879) | 2.59674335 |
| 108 | amino-acid betaine transport (GO:0015838) | 2.59674335 |
| 109 | glutamate metabolic process (GO:0006536) | 2.59421742 |
| 110 | lysine catabolic process (GO:0006554) | 2.58561362 |
| 111 | lysine metabolic process (GO:0006553) | 2.58561362 |
| 112 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.58488150 |
| 113 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.57413525 |
| 114 | regulation of ARF protein signal transduction (GO:0032012) | 2.57212423 |
| 115 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.57003861 |
| 116 | potassium ion import (GO:0010107) | 2.56307247 |
| 117 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.55925466 |
| 118 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.55925466 |
| 119 | muscle cell cellular homeostasis (GO:0046716) | 2.55132591 |
| 120 | muscle adaptation (GO:0043500) | 2.54547804 |
| 121 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.54307441 |
| 122 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.52575572 |
| 123 | dendrite morphogenesis (GO:0048813) | 2.51782357 |
| 124 | myoblast fusion (GO:0007520) | 2.49792665 |
| 125 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.48834188 |
| 126 | organelle transport along microtubule (GO:0072384) | 2.48269877 |
| 127 | regulation of muscle adaptation (GO:0043502) | 2.47372199 |
| 128 | regulation of membrane repolarization (GO:0060306) | 2.47336771 |
| 129 | muscle atrophy (GO:0014889) | 2.45729998 |
| 130 | membrane depolarization during action potential (GO:0086010) | 2.44925339 |
| 131 | establishment of nucleus localization (GO:0040023) | 2.44374986 |
| 132 | 2-oxoglutarate metabolic process (GO:0006103) | 2.43813734 |
| 133 | regulation of cell communication by electrical coupling (GO:0010649) | 2.43365833 |
| 134 | cerebellar Purkinje cell layer development (GO:0021680) | 2.41828420 |
| 135 | neuromuscular process controlling balance (GO:0050885) | 2.41660897 |
| 136 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.40542793 |
| 137 | protein localization to synapse (GO:0035418) | 2.39926882 |
| 138 | regulation of cardiac muscle contraction (GO:0055117) | 2.38857778 |
| 139 | neurotransmitter transport (GO:0006836) | 2.38850561 |
| 140 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.37562900 |
| 141 | innervation (GO:0060384) | 2.37228949 |
| 142 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.36665844 |
| 143 | detection of calcium ion (GO:0005513) | 2.36368320 |
| 144 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.35790523 |
| 145 | cellular sodium ion homeostasis (GO:0006883) | 2.35715169 |
| 146 | positive regulation of synapse maturation (GO:0090129) | 2.34503640 |
| 147 | alanine transport (GO:0032328) | 2.34255535 |
| 148 | aspartate family amino acid catabolic process (GO:0009068) | 2.33866678 |
| 149 | dendritic spine morphogenesis (GO:0060997) | 2.33464404 |
| 150 | dicarboxylic acid catabolic process (GO:0043649) | 2.33015606 |
| 151 | long-term memory (GO:0007616) | 2.31116503 |
| 152 | glutamate receptor signaling pathway (GO:0007215) | 2.30961930 |
| 153 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.30390239 |
| 154 | regulation of neurotransmitter levels (GO:0001505) | 2.29715574 |
| 155 | positive regulation of muscle hypertrophy (GO:0014742) | 2.29443662 |
| 156 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.29443662 |
| 157 | regulation of synaptic plasticity (GO:0048167) | 2.28877518 |
| 158 | neuromuscular junction development (GO:0007528) | 2.27159203 |
| 159 | glycogen catabolic process (GO:0005980) | 2.26340311 |
| 160 | neuron-neuron synaptic transmission (GO:0007270) | 2.25601471 |
| 161 | negative regulation of sodium ion transport (GO:0010766) | 2.25090652 |
| 162 | regulation of postsynaptic membrane potential (GO:0060078) | 2.24969557 |
| 163 | alpha-linolenic acid metabolic process (GO:0036109) | 2.24739456 |
| 164 | synaptic transmission, glutamatergic (GO:0035249) | 2.24172512 |
| 165 | nerve growth factor signaling pathway (GO:0038180) | 2.24148537 |
| 166 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.23745979 |
| 167 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.23279440 |
| 168 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.22448989 |
| 169 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.21969560 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.19834983 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.60891295 |
| 3 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.25439907 |
| 4 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.19343219 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.07340865 |
| 6 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.06511818 |
| 7 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.06112525 |
| 8 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.04548990 |
| 9 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.04103214 |
| 10 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.92069290 |
| 11 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.91783818 |
| 12 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.87252354 |
| 13 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.86777889 |
| 14 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.82871657 |
| 15 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.82871657 |
| 16 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.82535459 |
| 17 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.79366849 |
| 18 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.76567499 |
| 19 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.74829663 |
| 20 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.72803544 |
| 21 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.68081815 |
| 22 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.67888271 |
| 23 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.65946590 |
| 24 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.62958738 |
| 25 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.62833277 |
| 26 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.59786269 |
| 27 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.59645046 |
| 28 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.57590553 |
| 29 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.57551266 |
| 30 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.57154222 |
| 31 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.53240623 |
| 32 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.52816451 |
| 33 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.52494856 |
| 34 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.52294701 |
| 35 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.50203775 |
| 36 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.49902428 |
| 37 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.47827572 |
| 38 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.47664931 |
| 39 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.44866349 |
| 40 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.44270239 |
| 41 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.41814729 |
| 42 | GATA1_22025678_ChIP-Seq_K562_Human | 1.41395167 |
| 43 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.41248102 |
| 44 | FUS_26573619_Chip-Seq_HEK293_Human | 1.40257259 |
| 45 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.40153430 |
| 46 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.40153430 |
| 47 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.40028071 |
| 48 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.39634640 |
| 49 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.39537155 |
| 50 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.39336648 |
| 51 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.38589558 |
| 52 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.38503808 |
| 53 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.37299726 |
| 54 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.36799668 |
| 55 | TP53_16413492_ChIP-PET_HCT116_Human | 1.34444065 |
| 56 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.34352222 |
| 57 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.33832621 |
| 58 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.33611659 |
| 59 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.33574209 |
| 60 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.32999293 |
| 61 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.32523542 |
| 62 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.31551176 |
| 63 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.31147366 |
| 64 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.30946088 |
| 65 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.30528650 |
| 66 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.30516987 |
| 67 | AR_19668381_ChIP-Seq_PC3_Human | 1.30258437 |
| 68 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.30140186 |
| 69 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.29753907 |
| 70 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.28766794 |
| 71 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.27426590 |
| 72 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.27363366 |
| 73 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.26966626 |
| 74 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.25735550 |
| 75 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.25557919 |
| 76 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.25312690 |
| 77 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.22681557 |
| 78 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.21126398 |
| 79 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.21059272 |
| 80 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.20870429 |
| 81 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.20498129 |
| 82 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.20084545 |
| 83 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.20041990 |
| 84 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.19923340 |
| 85 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.19040544 |
| 86 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.18972221 |
| 87 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.18789514 |
| 88 | RXR_22108803_ChIP-Seq_LS180_Human | 1.18352203 |
| 89 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.18338186 |
| 90 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.17213282 |
| 91 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.15346263 |
| 92 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.15004078 |
| 93 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.14902259 |
| 94 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.14537256 |
| 95 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.14339870 |
| 96 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.13268994 |
| 97 | AR_25329375_ChIP-Seq_VCAP_Human | 1.12618398 |
| 98 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.11842823 |
| 99 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.11587257 |
| 100 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.10711807 |
| 101 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.10411766 |
| 102 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10377378 |
| 103 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.09315093 |
| 104 | TCF4_23295773_ChIP-Seq_U87_Human | 1.08181695 |
| 105 | KDM2B_26808549_Chip-Seq_K562_Human | 1.08171169 |
| 106 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.07847809 |
| 107 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.07807341 |
| 108 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.07369541 |
| 109 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.07265769 |
| 110 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.06794623 |
| 111 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.06775606 |
| 112 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.06260187 |
| 113 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.05914119 |
| 114 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.05727944 |
| 115 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.05392007 |
| 116 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.05257293 |
| 117 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.04060100 |
| 118 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.02514089 |
| 119 | CJUN_26792858_Chip-Seq_BT549_Human | 1.02076106 |
| 120 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.01626992 |
| 121 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.01163399 |
| 122 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.01083076 |
| 123 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.00723826 |
| 124 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.00073750 |
| 125 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.00073750 |
| 126 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.99917752 |
| 127 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.99020564 |
| 128 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.98551656 |
| 129 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.98329302 |
| 130 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.97772393 |
| 131 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.97678630 |
| 132 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.96013921 |
| 133 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.95575016 |
| 134 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.95285051 |
| 135 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.94870629 |
| 136 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.94165106 |
| 137 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.91215187 |
| 138 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.90322239 |
| 139 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.89663473 |
| 140 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.87252378 |
| 141 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.86352901 |
| 142 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85593045 |
| 143 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.85143503 |
| 144 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.85007990 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.82563852 |
| 2 | MP0004270_analgesia | 3.32713729 |
| 3 | MP0002837_dystrophic_cardiac_calcinosis | 2.89463692 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 2.84381731 |
| 5 | MP0000751_myopathy | 2.70469017 |
| 6 | MP0009780_abnormal_chondrocyte_physiolo | 2.53900436 |
| 7 | MP0004130_abnormal_muscle_cell | 2.44069072 |
| 8 | MP0004145_abnormal_muscle_electrophysio | 2.43692937 |
| 9 | MP0002139_abnormal_hepatobiliary_system | 2.38055948 |
| 10 | MP0002063_abnormal_learning/memory/cond | 2.20965893 |
| 11 | MP0003880_abnormal_central_pattern | 2.19822452 |
| 12 | MP0002332_abnormal_exercise_endurance | 2.19792922 |
| 13 | MP0009046_muscle_twitch | 2.16651960 |
| 14 | MP0005085_abnormal_gallbladder_physiolo | 2.15960776 |
| 15 | MP0009745_abnormal_behavioral_response | 2.10817896 |
| 16 | MP0003646_muscle_fatigue | 2.10344132 |
| 17 | MP0002064_seizures | 2.07950336 |
| 18 | MP0005360_urolithiasis | 2.05935397 |
| 19 | MP0002909_abnormal_adrenal_gland | 2.00458868 |
| 20 | MP0005365_abnormal_bile_salt | 1.99074937 |
| 21 | MP0002822_catalepsy | 1.92708231 |
| 22 | MP0000569_abnormal_digit_pigmentation | 1.92167218 |
| 23 | MP0003950_abnormal_plasma_membrane | 1.88777160 |
| 24 | MP0005451_abnormal_body_composition | 1.83787352 |
| 25 | MP0004215_abnormal_myocardial_fiber | 1.79320177 |
| 26 | MP0000749_muscle_degeneration | 1.76339786 |
| 27 | MP0004036_abnormal_muscle_relaxation | 1.74331395 |
| 28 | MP0000747_muscle_weakness | 1.73607624 |
| 29 | MP0002572_abnormal_emotion/affect_behav | 1.72141798 |
| 30 | MP0002734_abnormal_mechanical_nocicepti | 1.68298690 |
| 31 | MP0001661_extended_life_span | 1.66192533 |
| 32 | MP0000750_abnormal_muscle_regeneration | 1.63094721 |
| 33 | MP0001486_abnormal_startle_reflex | 1.61357580 |
| 34 | MP0000733_abnormal_muscle_development | 1.61258325 |
| 35 | MP0008961_abnormal_basal_metabolism | 1.60270662 |
| 36 | MP0003252_abnormal_bile_duct | 1.57812469 |
| 37 | MP0002272_abnormal_nervous_system | 1.56944404 |
| 38 | MP0010234_abnormal_vibrissa_follicle | 1.56483797 |
| 39 | MP0004087_abnormal_muscle_fiber | 1.55726051 |
| 40 | MP0004084_abnormal_cardiac_muscle | 1.52979600 |
| 41 | MP0003329_amyloid_beta_deposits | 1.51478116 |
| 42 | MP0002269_muscular_atrophy | 1.48999230 |
| 43 | MP0004233_abnormal_muscle_weight | 1.47465454 |
| 44 | MP0001968_abnormal_touch/_nociception | 1.46248282 |
| 45 | MP0005620_abnormal_muscle_contractility | 1.43845844 |
| 46 | MP0010329_abnormal_lipoprotein_level | 1.39708465 |
| 47 | MP0002127_abnormal_cardiovascular_syste | 1.39613616 |
| 48 | MP0000013_abnormal_adipose_tissue | 1.38236645 |
| 49 | MP0004510_myositis | 1.36732575 |
| 50 | MP0008875_abnormal_xenobiotic_pharmacok | 1.34074693 |
| 51 | MP0004811_abnormal_neuron_physiology | 1.32478843 |
| 52 | MP0004924_abnormal_behavior | 1.31843283 |
| 53 | MP0005386_behavior/neurological_phenoty | 1.31843283 |
| 54 | MP0003633_abnormal_nervous_system | 1.30295903 |
| 55 | MP0001440_abnormal_grooming_behavior | 1.30075828 |
| 56 | MP0005330_cardiomyopathy | 1.27687189 |
| 57 | MP0004484_altered_response_of | 1.27587141 |
| 58 | MP0002067_abnormal_sensory_capabilities | 1.26619210 |
| 59 | MP0001501_abnormal_sleep_pattern | 1.26301453 |
| 60 | MP0005385_cardiovascular_system_phenoty | 1.26071886 |
| 61 | MP0001544_abnormal_cardiovascular_syste | 1.26071886 |
| 62 | MP0008569_lethality_at_weaning | 1.24689156 |
| 63 | MP0004858_abnormal_nervous_system | 1.22258745 |
| 64 | MP0004185_abnormal_adipocyte_glucose | 1.19540785 |
| 65 | MP0004085_abnormal_heartbeat | 1.19237016 |
| 66 | MP0000759_abnormal_skeletal_muscle | 1.18681780 |
| 67 | MP0004043_abnormal_pH_regulation | 1.18542821 |
| 68 | MP0005666_abnormal_adipose_tissue | 1.17475278 |
| 69 | MP0002106_abnormal_muscle_physiology | 1.15386358 |
| 70 | MP0005187_abnormal_penis_morphology | 1.14173309 |
| 71 | MP0003221_abnormal_cardiomyocyte_apopto | 1.12678278 |
| 72 | MP0005646_abnormal_pituitary_gland | 1.12574391 |
| 73 | MP0002735_abnormal_chemical_nociception | 1.09301771 |
| 74 | MP0002972_abnormal_cardiac_muscle | 1.09191604 |
| 75 | MP0004885_abnormal_endolymph | 1.09070784 |
| 76 | MP0002733_abnormal_thermal_nociception | 1.07200093 |
| 77 | MP0003690_abnormal_glial_cell | 1.06402378 |
| 78 | MP0005423_abnormal_somatic_nervous | 1.04786730 |
| 79 | MP0003705_abnormal_hypodermis_morpholog | 1.03769137 |
| 80 | MP0005535_abnormal_body_temperature | 1.03501956 |
| 81 | MP0003195_calcinosis | 1.02274671 |
| 82 | MP0005369_muscle_phenotype | 1.00837292 |
| 83 | MP0005375_adipose_tissue_phenotype | 1.00784015 |
| 84 | MP0008874_decreased_physiological_sensi | 1.00668197 |
| 85 | MP0002118_abnormal_lipid_homeostasis | 1.00607473 |
| 86 | MP0002066_abnormal_motor_capabilities/c | 0.99615837 |
| 87 | MP0000003_abnormal_adipose_tissue | 0.99564964 |
| 88 | MP0003631_nervous_system_phenotype | 0.98662824 |
| 89 | MP0002557_abnormal_social/conspecific_i | 0.97785094 |
| 90 | MP0003045_fibrosis | 0.97533854 |
| 91 | MP0010352_gastrointestinal_tract_polyps | 0.96470418 |
| 92 | MP0002009_preneoplasia | 0.96378257 |
| 93 | MP0001299_abnormal_eye_distance/ | 0.96134363 |
| 94 | MP0003828_pulmonary_edema | 0.96063673 |
| 95 | MP0002078_abnormal_glucose_homeostasis | 0.95579724 |
| 96 | MP0003137_abnormal_impulse_conducting | 0.95245094 |
| 97 | MP0000955_abnormal_spinal_cord | 0.94620775 |
| 98 | MP0001970_abnormal_pain_threshold | 0.94320440 |
| 99 | MP0004134_abnormal_chest_morphology | 0.94135249 |
| 100 | MP0000778_abnormal_nervous_system | 0.93588950 |
| 101 | MP0005332_abnormal_amino_acid | 0.90624010 |
| 102 | MP0010368_abnormal_lymphatic_system | 0.89529496 |
| 103 | MP0002184_abnormal_innervation | 0.86090312 |
| 104 | MP0006138_congestive_heart_failure | 0.86002476 |
| 105 | MP0005409_darkened_coat_color | 0.85367014 |
| 106 | MP0002971_abnormal_brown_adipose | 0.83851026 |
| 107 | MP0003879_abnormal_hair_cell | 0.83554042 |
| 108 | MP0002882_abnormal_neuron_morphology | 0.83099597 |
| 109 | MP0005266_abnormal_metabolism | 0.83099436 |
| 110 | MP0010630_abnormal_cardiac_muscle | 0.82784794 |
| 111 | MP0008775_abnormal_heart_ventricle | 0.82666409 |
| 112 | MP0003283_abnormal_digestive_organ | 0.81790109 |
| 113 | MP0002736_abnormal_nociception_after | 0.81788982 |
| 114 | MP0000604_amyloidosis | 0.81401434 |
| 115 | MP0002108_abnormal_muscle_morphology | 0.81204294 |
| 116 | MP0000266_abnormal_heart_morphology | 0.80987493 |
| 117 | MP0005670_abnormal_white_adipose | 0.80008208 |
| 118 | MP0002229_neurodegeneration | 0.78184443 |
| 119 | MP0003868_abnormal_feces_composition | 0.77451489 |
| 120 | MP0003656_abnormal_erythrocyte_physiolo | 0.77203628 |
| 121 | MP0008438_abnormal_cutaneous_collagen | 0.75765068 |
| 122 | MP0005275_abnormal_skin_tensile | 0.75161891 |
| 123 | MP0000462_abnormal_digestive_system | 0.71439455 |
| 124 | MP0008057_abnormal_DNA_replication | 0.71215808 |
| 125 | MP0004272_abnormal_basement_membrane | 0.67618427 |
| 126 | MP0002896_abnormal_bone_mineralization | 0.65078852 |
| 127 | MP0001177_atelectasis | 0.65004120 |
| 128 | MP0002128_abnormal_blood_circulation | 0.63909479 |
| 129 | MP0010678_abnormal_skin_adnexa | 0.62878568 |
| 130 | MP0003091_abnormal_cell_migration | 0.58067850 |
| 131 | MP0009115_abnormal_fat_cell | 0.55568946 |
| 132 | MP0005248_abnormal_Harderian_gland | 0.54697153 |
| 133 | MP0010386_abnormal_urinary_bladder | 0.52617530 |
| 134 | MP0003890_abnormal_embryonic-extraembry | 0.52381254 |
| 135 | MP0002168_other_aberrant_phenotype | 0.51416026 |
| 136 | MP0003385_abnormal_body_wall | 0.49833852 |
| 137 | MP0001879_abnormal_lymphatic_vessel | 0.48765948 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.28400458 |
| 2 | Subaortic stenosis (HP:0001682) | 4.28400458 |
| 3 | Exercise-induced myalgia (HP:0003738) | 4.15691199 |
| 4 | Focal motor seizures (HP:0011153) | 4.12847716 |
| 5 | Focal seizures (HP:0007359) | 3.81714791 |
| 6 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.45919145 |
| 7 | Rimmed vacuoles (HP:0003805) | 3.45853430 |
| 8 | Round ear (HP:0100830) | 3.43981592 |
| 9 | Myopathic facies (HP:0002058) | 3.43606702 |
| 10 | Neck muscle weakness (HP:0000467) | 3.43174275 |
| 11 | Myokymia (HP:0002411) | 3.37728789 |
| 12 | Hyporeflexia of lower limbs (HP:0002600) | 3.27244304 |
| 13 | Dysmetric saccades (HP:0000641) | 3.21111524 |
| 14 | Exercise-induced muscle cramps (HP:0003710) | 3.16991823 |
| 15 | Visual hallucinations (HP:0002367) | 3.14758314 |
| 16 | Sudden death (HP:0001699) | 3.14094551 |
| 17 | Rhabdomyolysis (HP:0003201) | 3.12829038 |
| 18 | Ventricular tachycardia (HP:0004756) | 3.11621077 |
| 19 | Action tremor (HP:0002345) | 3.04662885 |
| 20 | Difficulty running (HP:0009046) | 3.01200115 |
| 21 | Hyperventilation (HP:0002883) | 2.95327746 |
| 22 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.92683189 |
| 23 | Asymmetric septal hypertrophy (HP:0001670) | 2.90489216 |
| 24 | Ulnar deviation of the wrist (HP:0003049) | 2.87980356 |
| 25 | Abnormal social behavior (HP:0012433) | 2.87566632 |
| 26 | Impaired social interactions (HP:0000735) | 2.87566632 |
| 27 | Calf muscle hypertrophy (HP:0008981) | 2.86417802 |
| 28 | Epileptic encephalopathy (HP:0200134) | 2.83214149 |
| 29 | Distal lower limb muscle weakness (HP:0009053) | 2.76444407 |
| 30 | Progressive cerebellar ataxia (HP:0002073) | 2.73473579 |
| 31 | Postural instability (HP:0002172) | 2.72883747 |
| 32 | Poor eye contact (HP:0000817) | 2.72671754 |
| 33 | Generalized tonic-clonic seizures (HP:0002069) | 2.69101660 |
| 34 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.69002272 |
| 35 | Termporal pattern (HP:0011008) | 2.67872130 |
| 36 | Insidious onset (HP:0003587) | 2.67872130 |
| 37 | Myoglobinuria (HP:0002913) | 2.63502620 |
| 38 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.59153127 |
| 39 | Absence seizures (HP:0002121) | 2.57854599 |
| 40 | Heart block (HP:0012722) | 2.55257056 |
| 41 | Ketoacidosis (HP:0001993) | 2.54410458 |
| 42 | Genetic anticipation (HP:0003743) | 2.54309643 |
| 43 | Dysdiadochokinesis (HP:0002075) | 2.54051142 |
| 44 | Areflexia of lower limbs (HP:0002522) | 2.52344171 |
| 45 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.51931149 |
| 46 | Dilated cardiomyopathy (HP:0001644) | 2.51095212 |
| 47 | Broad-based gait (HP:0002136) | 2.49619312 |
| 48 | Bundle branch block (HP:0011710) | 2.48488071 |
| 49 | Papillary thyroid carcinoma (HP:0002895) | 2.47688082 |
| 50 | Abnormality of the calf musculature (HP:0001430) | 2.45917702 |
| 51 | Lipoatrophy (HP:0100578) | 2.45116452 |
| 52 | Distal lower limb amyotrophy (HP:0008944) | 2.43842591 |
| 53 | Fetal akinesia sequence (HP:0001989) | 2.42338151 |
| 54 | Ketosis (HP:0001946) | 2.42007419 |
| 55 | Muscle fiber splitting (HP:0003555) | 2.38344917 |
| 56 | Abnormal atrioventricular conduction (HP:0005150) | 2.37904080 |
| 57 | Atonic seizures (HP:0010819) | 2.36787894 |
| 58 | Calcaneovalgus deformity (HP:0001848) | 2.36226957 |
| 59 | Muscle fiber inclusion bodies (HP:0100299) | 2.33728696 |
| 60 | Dialeptic seizures (HP:0011146) | 2.29168473 |
| 61 | Excessive salivation (HP:0003781) | 2.27677634 |
| 62 | Drooling (HP:0002307) | 2.27677634 |
| 63 | Type 1 muscle fiber predominance (HP:0003803) | 2.26617186 |
| 64 | Status epilepticus (HP:0002133) | 2.26547039 |
| 65 | Syncope (HP:0001279) | 2.25717020 |
| 66 | Depression (HP:0000716) | 2.25502244 |
| 67 | Absent phalangeal crease (HP:0006109) | 2.25450162 |
| 68 | EMG: myopathic abnormalities (HP:0003458) | 2.25092925 |
| 69 | Epileptiform EEG discharges (HP:0011182) | 2.24971636 |
| 70 | Increased variability in muscle fiber diameter (HP:0003557) | 2.24840698 |
| 71 | Myotonia (HP:0002486) | 2.24661277 |
| 72 | EEG with generalized epileptiform discharges (HP:0011198) | 2.23727277 |
| 73 | Urinary urgency (HP:0000012) | 2.23678868 |
| 74 | Hypsarrhythmia (HP:0002521) | 2.22268750 |
| 75 | Scapular winging (HP:0003691) | 2.21933764 |
| 76 | Macroorchidism (HP:0000053) | 2.21755569 |
| 77 | Deep venous thrombosis (HP:0002625) | 2.21556376 |
| 78 | Dysmetria (HP:0001310) | 2.21150119 |
| 79 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.21100205 |
| 80 | Abnormality of the lower motor neuron (HP:0002366) | 2.19653232 |
| 81 | Febrile seizures (HP:0002373) | 2.18228395 |
| 82 | Gaze-evoked nystagmus (HP:0000640) | 2.15644519 |
| 83 | Proximal amyotrophy (HP:0007126) | 2.14022381 |
| 84 | Pheochromocytoma (HP:0002666) | 2.12166459 |
| 85 | Generalized muscle weakness (HP:0003324) | 2.08761639 |
| 86 | Deformed tarsal bones (HP:0008119) | 2.06618672 |
| 87 | Malignant hyperthermia (HP:0002047) | 2.06581051 |
| 88 | Hip contracture (HP:0003273) | 2.06050704 |
| 89 | Hypoglycemic coma (HP:0001325) | 2.05305950 |
| 90 | Prolonged QT interval (HP:0001657) | 2.05190045 |
| 91 | Ventricular fibrillation (HP:0001663) | 2.04337530 |
| 92 | Abnormal finger flexion creases (HP:0006143) | 2.04118713 |
| 93 | Hypoalphalipoproteinemia (HP:0003233) | 2.03818896 |
| 94 | Hyperglycemia (HP:0003074) | 2.02236420 |
| 95 | Overgrowth (HP:0001548) | 2.02186838 |
| 96 | Muscular dystrophy (HP:0003560) | 2.01970688 |
| 97 | Slender build (HP:0001533) | 2.01340473 |
| 98 | Supranuclear gaze palsy (HP:0000605) | 2.00348479 |
| 99 | Abnormality of the ischium (HP:0003174) | 2.00029324 |
| 100 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.99806829 |
| 101 | Impaired vibratory sensation (HP:0002495) | 1.99762442 |
| 102 | Muscle stiffness (HP:0003552) | 1.98903888 |
| 103 | Abnormality of the foot musculature (HP:0001436) | 1.98623879 |
| 104 | Scanning speech (HP:0002168) | 1.96848229 |
| 105 | Resting tremor (HP:0002322) | 1.95650270 |
| 106 | Intention tremor (HP:0002080) | 1.94586433 |
| 107 | Xanthomatosis (HP:0000991) | 1.93825521 |
| 108 | Intrahepatic cholestasis (HP:0001406) | 1.92858697 |
| 109 | Supraventricular tachycardia (HP:0004755) | 1.92621891 |
| 110 | Abnormality of the Achilles tendon (HP:0005109) | 1.92579978 |
| 111 | Torticollis (HP:0000473) | 1.92230931 |
| 112 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.91766579 |
| 113 | Anxiety (HP:0000739) | 1.91645916 |
| 114 | Truncal ataxia (HP:0002078) | 1.91463663 |
| 115 | Spinal rigidity (HP:0003306) | 1.90323228 |
| 116 | Supraventricular arrhythmia (HP:0005115) | 1.89507083 |
| 117 | Limited hip movement (HP:0008800) | 1.89457940 |
| 118 | Atrioventricular block (HP:0001678) | 1.88663131 |
| 119 | Gowers sign (HP:0003391) | 1.87460303 |
| 120 | Foot dorsiflexor weakness (HP:0009027) | 1.85954305 |
| 121 | Lower limb amyotrophy (HP:0007210) | 1.85911737 |
| 122 | Atrial fibrillation (HP:0005110) | 1.84974893 |
| 123 | Cerebral inclusion bodies (HP:0100314) | 1.84484799 |
| 124 | Impaired smooth pursuit (HP:0007772) | 1.84479414 |
| 125 | Frequent falls (HP:0002359) | 1.83264803 |
| 126 | Increased connective tissue (HP:0009025) | 1.82702062 |
| 127 | Right ventricular cardiomyopathy (HP:0011663) | 1.82502258 |
| 128 | Central scotoma (HP:0000603) | 1.82162270 |
| 129 | Ankle clonus (HP:0011448) | 1.81082909 |
| 130 | Epidermoid cyst (HP:0200040) | 1.80732488 |
| 131 | Long clavicles (HP:0000890) | 1.79975792 |
| 132 | Achilles tendon contracture (HP:0001771) | 1.79532781 |
| 133 | EMG: neuropathic changes (HP:0003445) | 1.79323249 |
| 134 | Distal arthrogryposis (HP:0005684) | 1.79294286 |
| 135 | Nemaline bodies (HP:0003798) | 1.79251658 |
| 136 | Gout (HP:0001997) | 1.78453702 |
| 137 | Abnormality of the corticospinal tract (HP:0002492) | 1.78173877 |
| 138 | Primary atrial arrhythmia (HP:0001692) | 1.77356410 |
| 139 | Hemiplegia (HP:0002301) | 1.76201378 |
| 140 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.75844454 |
| 141 | Hypoplastic ischia (HP:0003175) | 1.74962626 |
| 142 | Hyperkalemia (HP:0002153) | 1.74942184 |
| 143 | Focal dystonia (HP:0004373) | 1.74138300 |
| 144 | Hyperlipoproteinemia (HP:0010980) | 1.73547413 |
| 145 | Absent speech (HP:0001344) | 1.73259025 |
| 146 | Ventricular arrhythmia (HP:0004308) | 1.72817920 |
| 147 | Metatarsus adductus (HP:0001840) | 1.69035475 |
| 148 | Difficulty climbing stairs (HP:0003551) | 1.63443723 |
| 149 | Steppage gait (HP:0003376) | 1.61650366 |
| 150 | Bulbar palsy (HP:0001283) | 1.57104225 |
| 151 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.55728529 |
| 152 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.54541134 |
| 153 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.54541134 |
| 154 | Ulnar deviation of finger (HP:0009465) | 1.53592173 |
| 155 | Fatigable weakness (HP:0003473) | 1.50613406 |
| 156 | Abnormality of the neuromuscular junction (HP:0003398) | 1.50613406 |
| 157 | Abnormal EKG (HP:0003115) | 1.50421232 |
| 158 | Limb-girdle muscle weakness (HP:0003325) | 1.49325193 |
| 159 | Limb-girdle muscle atrophy (HP:0003797) | 1.49063947 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 3.40250536 |
| 2 | MAP3K4 | 3.14927195 |
| 3 | MAP3K9 | 3.09322866 |
| 4 | EPHA4 | 2.87306643 |
| 5 | MAP2K4 | 2.63114379 |
| 6 | PIK3CG | 2.17371812 |
| 7 | PAK6 | 2.15247935 |
| 8 | KSR2 | 2.02653815 |
| 9 | PHKG2 | 1.96913518 |
| 10 | PHKG1 | 1.96913518 |
| 11 | MAP2K7 | 1.88388726 |
| 12 | DAPK2 | 1.85837517 |
| 13 | MINK1 | 1.75720251 |
| 14 | TRPM7 | 1.70134226 |
| 15 | INSRR | 1.68650474 |
| 16 | OBSCN | 1.67504352 |
| 17 | MARK1 | 1.65841676 |
| 18 | MAP3K2 | 1.62779285 |
| 19 | CAMK1G | 1.60920533 |
| 20 | CAMKK1 | 1.59581809 |
| 21 | CASK | 1.56453531 |
| 22 | TTN | 1.48420173 |
| 23 | KSR1 | 1.48328185 |
| 24 | DMPK | 1.48095642 |
| 25 | FGFR3 | 1.46486517 |
| 26 | NTRK1 | 1.46399754 |
| 27 | PRKD3 | 1.42857308 |
| 28 | PNCK | 1.40234687 |
| 29 | RET | 1.38633394 |
| 30 | MAP3K7 | 1.36210071 |
| 31 | STK38 | 1.36193615 |
| 32 | TRIB3 | 1.34006857 |
| 33 | PAK3 | 1.31611262 |
| 34 | EEF2K | 1.27165907 |
| 35 | RIPK4 | 1.24220200 |
| 36 | SGK3 | 1.22768474 |
| 37 | CDK5 | 1.20460685 |
| 38 | RIPK1 | 1.18922465 |
| 39 | ERBB3 | 1.18099040 |
| 40 | PKN2 | 1.16925562 |
| 41 | NEK9 | 1.16593176 |
| 42 | PDK4 | 1.11306179 |
| 43 | PDK3 | 1.11306179 |
| 44 | LATS2 | 1.08403539 |
| 45 | CAMK1D | 1.07435856 |
| 46 | NTRK2 | 1.07246718 |
| 47 | SGK2 | 1.06604005 |
| 48 | LMTK2 | 1.06433142 |
| 49 | NEK1 | 1.04532795 |
| 50 | FGFR2 | 1.04072049 |
| 51 | FRK | 1.03787473 |
| 52 | CAMKK2 | 1.00526928 |
| 53 | BRD4 | 0.99254291 |
| 54 | SGK494 | 0.97593548 |
| 55 | SGK223 | 0.97593548 |
| 56 | SIK1 | 0.97578173 |
| 57 | PINK1 | 0.94227705 |
| 58 | WNK1 | 0.94058603 |
| 59 | FER | 0.93992053 |
| 60 | STK11 | 0.93829873 |
| 61 | MUSK | 0.93485760 |
| 62 | PRKCH | 0.92320918 |
| 63 | PDK1 | 0.90293336 |
| 64 | TAOK1 | 0.85166425 |
| 65 | UHMK1 | 0.84380826 |
| 66 | PDPK1 | 0.82212905 |
| 67 | CDK12 | 0.82119810 |
| 68 | CAMK1 | 0.82022916 |
| 69 | CCNB1 | 0.80391215 |
| 70 | TYRO3 | 0.80319183 |
| 71 | PDGFRA | 0.80186614 |
| 72 | MAPK12 | 0.79046047 |
| 73 | SGK1 | 0.77445444 |
| 74 | MAP3K1 | 0.76014929 |
| 75 | LATS1 | 0.76014322 |
| 76 | PDK2 | 0.74350246 |
| 77 | CAMK2A | 0.74260248 |
| 78 | BCKDK | 0.73715495 |
| 79 | PRKCG | 0.72927965 |
| 80 | ROCK1 | 0.72160077 |
| 81 | ALK | 0.69626207 |
| 82 | PRKAA1 | 0.68730361 |
| 83 | SCYL2 | 0.68551543 |
| 84 | MAP3K6 | 0.67671292 |
| 85 | WNK4 | 0.66115640 |
| 86 | EPHA3 | 0.65785503 |
| 87 | PTK2B | 0.63017388 |
| 88 | CAMK2B | 0.62500759 |
| 89 | NLK | 0.61531726 |
| 90 | CAMK4 | 0.59870400 |
| 91 | PLK2 | 0.59806481 |
| 92 | CAMK2G | 0.59767547 |
| 93 | RPS6KA3 | 0.59742878 |
| 94 | OXSR1 | 0.58746524 |
| 95 | MAP2K3 | 0.58453955 |
| 96 | PIK3CA | 0.58278454 |
| 97 | MAP3K13 | 0.58223972 |
| 98 | FES | 0.57311502 |
| 99 | MAP2K1 | 0.56834340 |
| 100 | MTOR | 0.56544837 |
| 101 | STK39 | 0.55658593 |
| 102 | PRKG1 | 0.55452806 |
| 103 | MAPK7 | 0.55351602 |
| 104 | DAPK1 | 0.55076461 |
| 105 | PTK6 | 0.53322547 |
| 106 | CDC42BPA | 0.53245850 |
| 107 | JAK1 | 0.52857770 |
| 108 | PDGFRB | 0.51735870 |
| 109 | ICK | 0.51135225 |
| 110 | RPS6KB1 | 0.51054996 |
| 111 | MARK2 | 0.50930147 |
| 112 | PRKAA2 | 0.50577338 |
| 113 | CAMK2D | 0.50227348 |
| 114 | STK38L | 0.49860604 |
| 115 | SIK2 | 0.49725302 |
| 116 | CDK19 | 0.49293877 |
| 117 | AKT2 | 0.48489270 |
| 118 | GRK5 | 0.48042244 |
| 119 | MYLK | 0.47454194 |
| 120 | RAF1 | 0.46276408 |
| 121 | AKT3 | 0.46218447 |
| 122 | CDK18 | 0.46155445 |
| 123 | MAP3K5 | 0.45888613 |
| 124 | PRKD1 | 0.45501633 |
| 125 | CDK14 | 0.45368383 |
| 126 | MAPK10 | 0.45294405 |
| 127 | PTK2 | 0.45198543 |
| 128 | CSNK1G2 | 0.45000295 |
| 129 | TNIK | 0.44417221 |
| 130 | MAPK13 | 0.44044881 |
| 131 | NEK6 | 0.42691684 |
| 132 | STK24 | 0.40687865 |
| 133 | PRKACB | 0.36258933 |
| 134 | MAPKAPK3 | 0.36074856 |
| 135 | PRKCE | 0.32028537 |
| 136 | YES1 | 0.31494134 |
| 137 | FGFR1 | 0.31009149 |
| 138 | MAPK4 | 0.30758646 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.04439391 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.62050306 |
| 3 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.90983787 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.81481439 |
| 5 | Long-term potentiation_Homo sapiens_hsa04720 | 1.81281879 |
| 6 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.78145194 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 1.74358179 |
| 8 | Insulin secretion_Homo sapiens_hsa04911 | 1.66415885 |
| 9 | GABAergic synapse_Homo sapiens_hsa04727 | 1.63506111 |
| 10 | Nicotine addiction_Homo sapiens_hsa05033 | 1.62883224 |
| 11 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.60124930 |
| 12 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.59774028 |
| 13 | Olfactory transduction_Homo sapiens_hsa04740 | 1.53111205 |
| 14 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.52855869 |
| 15 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.52131464 |
| 16 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.51869512 |
| 17 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.50117652 |
| 18 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.46442090 |
| 19 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.45593826 |
| 20 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.45248431 |
| 21 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.45206083 |
| 22 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.42097390 |
| 23 | Salivary secretion_Homo sapiens_hsa04970 | 1.41238232 |
| 24 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.41058030 |
| 25 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.41057940 |
| 26 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.39689393 |
| 27 | Renin secretion_Homo sapiens_hsa04924 | 1.35119143 |
| 28 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.34145504 |
| 29 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.32072538 |
| 30 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.29015221 |
| 31 | Morphine addiction_Homo sapiens_hsa05032 | 1.28501881 |
| 32 | Bile secretion_Homo sapiens_hsa04976 | 1.26130319 |
| 33 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.23027645 |
| 34 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.18212086 |
| 35 | Endometrial cancer_Homo sapiens_hsa05213 | 1.15408008 |
| 36 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.15323820 |
| 37 | Adherens junction_Homo sapiens_hsa04520 | 1.12601360 |
| 38 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.12330398 |
| 39 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.11887895 |
| 40 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.10266470 |
| 41 | Focal adhesion_Homo sapiens_hsa04510 | 1.09771088 |
| 42 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.09716567 |
| 43 | Long-term depression_Homo sapiens_hsa04730 | 1.07592126 |
| 44 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.04956141 |
| 45 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.03240742 |
| 46 | Tight junction_Homo sapiens_hsa04530 | 1.02769143 |
| 47 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.00568476 |
| 48 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.96339209 |
| 49 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.94898567 |
| 50 | Glioma_Homo sapiens_hsa05214 | 0.92796760 |
| 51 | Gap junction_Homo sapiens_hsa04540 | 0.92728984 |
| 52 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.90277812 |
| 53 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.89522452 |
| 54 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.88790063 |
| 55 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.88754075 |
| 56 | Insulin resistance_Homo sapiens_hsa04931 | 0.88128986 |
| 57 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.88007052 |
| 58 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.87765947 |
| 59 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.87443490 |
| 60 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.86283191 |
| 61 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.86266943 |
| 62 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.85902743 |
| 63 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.85553355 |
| 64 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.85409107 |
| 65 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.83942123 |
| 66 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.82589319 |
| 67 | Taste transduction_Homo sapiens_hsa04742 | 0.81819921 |
| 68 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.80676377 |
| 69 | Cocaine addiction_Homo sapiens_hsa05030 | 0.80192062 |
| 70 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.78206355 |
| 71 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.78016459 |
| 72 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.75935103 |
| 73 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.75520344 |
| 74 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.74551601 |
| 75 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.74542654 |
| 76 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.74027036 |
| 77 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.73114797 |
| 78 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.72456938 |
| 79 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.71384784 |
| 80 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.69954223 |
| 81 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.69281255 |
| 82 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.68968263 |
| 83 | Carbon metabolism_Homo sapiens_hsa01200 | 0.68286841 |
| 84 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.68028604 |
| 85 | Melanogenesis_Homo sapiens_hsa04916 | 0.67728974 |
| 86 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.67341625 |
| 87 | Platelet activation_Homo sapiens_hsa04611 | 0.66176637 |
| 88 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.65054208 |
| 89 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.64854926 |
| 90 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.64787959 |
| 91 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.64280458 |
| 92 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.64014254 |
| 93 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.63649037 |
| 94 | Circadian rhythm_Homo sapiens_hsa04710 | 0.63516867 |
| 95 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.62965624 |
| 96 | Lysine degradation_Homo sapiens_hsa00310 | 0.62517254 |
| 97 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.60566333 |
| 98 | Amoebiasis_Homo sapiens_hsa05146 | 0.58554484 |
| 99 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.54450127 |
| 100 | Axon guidance_Homo sapiens_hsa04360 | 0.52389559 |
| 101 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.51922840 |
| 102 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.48874163 |
| 103 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.48209068 |
| 104 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.47938658 |
| 105 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.45684653 |
| 106 | Prion diseases_Homo sapiens_hsa05020 | 0.45595462 |
| 107 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.45377066 |
| 108 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.45156793 |
| 109 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.45149877 |
| 110 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.44686270 |
| 111 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.43511977 |
| 112 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.43173767 |
| 113 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.43005566 |
| 114 | Prostate cancer_Homo sapiens_hsa05215 | 0.42838380 |
| 115 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.42166003 |
| 116 | Colorectal cancer_Homo sapiens_hsa05210 | 0.41989059 |
| 117 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.41119373 |
| 118 | ABC transporters_Homo sapiens_hsa02010 | 0.41087649 |
| 119 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.39871386 |

